ShareValue scores for 0YAY.LSE: Valuation 50, Quality 16, Growth 34, Health 52.
0YAY.LSELSE
Vitrolife AB
£0.90
(+1.90%)
0YAY.LSELSE
Vitrolife AB
£0.90(+1.90%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Weak
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
4% to 17%
Rating
Trap Risk
Return
4% to 17%
Valuation
50
Fair Value
Price vs Value
Quality
16
Weak
Business Strength
Growth
34
Weak
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
15
Bearish
Price Trend
Company Details
About
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.
Sector
IndustryN/A
ExchangeLSE
Market Cap$524M
P/E RatioN/A
Dividend Yield0.37%
Sector Rank#2123
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026